Should You Do SS31 Before Mots C? | The Ongoing Debate
A growing coalition of health enthusiasts is debating whether starting with SS31 or Mots C yields the best results. Recent comments emphasize the lack of clinical data backing the sequencing of these supplements, adding to the ongoing discussion.
The Controversy Deepens
The crux of the argument remains whether taking SS31 enhances the effects of Mots C. While many advocates claim that SS31 aids mitochondrial restoration, a participant noted, "You don’t need to do SS31 before Mots. There’s really no clinical data at all to support the sequencing order." Another emphasized the anecdotal nature of some claims regarding these supplements.
Insights from Recent Discussions
New comments indicate a shift in attitudes regarding supplement timing:
One person shared a rotational approach, saying, "I keep them on a rotation: 2 vials of Mots C, then 1 vial of SS31. This works out to four cycles per year."
Countering some popular claims, others agree on the potential variance in personal experience—"Not one person here has all the answers. It’s about testing what works best for you.”
The Role of Age and Mitochondrial Health
Age and mitochondrial health are hot topics in this discourse:
Participants over 40 suggest starting with SS31 for optimal results. One remarked, "Today’s 2mg shot of Mots C combined with a moderate amount of carbs felt great for endurance and energy."
Conversely, young users, like one 34-year-old with insulin resistance, are choosing to run SS31 first despite experiencing initial fatigue.
"While it seems recommended to repair first, there are clearly mixed opinions," said an active commenter on the topic.
Exploring Different Protocols
Several users are mixing protocols to maximize their health outcomes:
Some people report using both supplements together successfully, aiming for enhanced energy, while others prefer a staggered approach.
A newcomer mentioned, "So far, taking 2mg of SS31 and 1mg of Mots C together has worked well for energy."
Key Observations
⚠️ Lack of Clinical Evidence: Concerns about the absence of solid data for supplement sequencing persist.
⚡ Personalized Protocols: Individuals share unique experiences; what works for one may not work for another.
🔁 Age Matters: Age influences how people approach these supplements, with older individuals leaning toward SS31 first for effective results.
The Road Ahead
As discussions progress, people are likely to adopt more individualized strategies by the close of 2026. The evolving nature of this conversation highlights that flexibility and personal experience will continue to shape supplement strategies.